Risk factor
Very poor trading liquidity
Profitability factor
Undervalued vs peers
About
Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim,...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, rea
Target Price
The average target price of PRM.MC is 17 and suggests 29% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell